These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8995014

  • 1. Zoledronate in the treatment of Paget's disease.
    Siris E.
    Br J Clin Pract Suppl; 1996 Sep; 87():19-20; discussion 22. PubMed ID: 8995014
    [No Abstract] [Full Text] [Related]

  • 2. Zoledronate treatment in active Paget's disease.
    Chung G, Keen RW.
    Ann Rheum Dis; 2003 Mar; 62(3):275-6. PubMed ID: 12594123
    [No Abstract] [Full Text] [Related]

  • 3. Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.
    Buckler H, Fraser W, Hosking D, Ryan W, Maricic MJ, Singer F, Davie M, Fogelman I, Birbara CA, Moses AM, Lyles K, Selby P, Richardson P, Seaman J, Zelenakas K, Siris E.
    Bone; 1999 May; 24(5 Suppl):81S-85S. PubMed ID: 10321935
    [No Abstract] [Full Text] [Related]

  • 4. Diphosphonates in Paget's disease.
    Russell RG, Smith R, Preston C, Walton RJ, Woods CG.
    Lancet; 1974 May 11; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract] [Full Text] [Related]

  • 5. Antiresorptive effect of a single infusion of microgram quantities of zoledronate in Paget's disease of bone.
    Arden-Cordone M, Siris ES, Lyles KW, Knieriem A, Newton RA, Schaffer V, Zelenakas K.
    Calcif Tissue Int; 1997 May 11; 60(5):415-8. PubMed ID: 9115157
    [Abstract] [Full Text] [Related]

  • 6. Strategies of treatment of Paget's disease with bisphosphonates.
    Papapoulos SE.
    Semin Arthritis Rheum; 1994 Feb 11; 23(4):265-6. PubMed ID: 8009248
    [No Abstract] [Full Text] [Related]

  • 7. [Zoledronic acid efficacy in Paget's disease of bone: a three-year experience].
    Conesa Mateos A, Rotés Sala D, Almirall Bernabé M, Carbonell Abelló J.
    Med Clin (Barc); 2006 Oct 28; 127(16):635-6. PubMed ID: 17145033
    [No Abstract] [Full Text] [Related]

  • 8. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R, Holz G, Minne H, Delling G.
    Verh Dtsch Ges Inn Med; 1978 Oct 28; (84):1122-5. PubMed ID: 741902
    [No Abstract] [Full Text] [Related]

  • 9. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A, Klar B, Scharla SH, Zieglar R.
    Semin Arthritis Rheum; 1994 Feb 28; 23(4):283-4. PubMed ID: 8009261
    [No Abstract] [Full Text] [Related]

  • 10. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P, Lévy P.
    Rev Rhum Mal Osteoartic; 1967 Apr 28; 34(4):185-92. PubMed ID: 6059924
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb 28; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 12. The use of zoledronic acid for Paget's disease of bone.
    Maricic M.
    Curr Osteoporos Rep; 2006 Mar 28; 4(1):40-4. PubMed ID: 16527007
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
    Kanis JA, Preston CJ, Beard DJ, Beneton M, Harris S, Russell RG.
    Bone; 1985 Mar 28; 6(2):69-72. PubMed ID: 2409999
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Paget's disease with a diphosphonate (sodium etidronate).
    Smith R, Russell RG.
    Semin Drug Treat; 1972 Mar 28; 2(1):77-81. PubMed ID: 4558759
    [No Abstract] [Full Text] [Related]

  • 15. Persistent effect of zoledronic acid in Paget's disease.
    Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F.
    Clin Exp Rheumatol; 2007 Mar 28; 25(3):464-6. PubMed ID: 17631747
    [Abstract] [Full Text] [Related]

  • 16. Zoledronic acid for treatment of Paget's disease of bone.
    Devogelaer JP, Manicourt DH.
    Expert Opin Pharmacother; 2007 Nov 28; 8(16):2863-9. PubMed ID: 17956205
    [Abstract] [Full Text] [Related]

  • 17. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D.
    N Engl J Med; 2005 Sep 01; 353(9):898-908. PubMed ID: 16135834
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Paget's disease--taming the wild osteoclast.
    Deftos LJ.
    N Engl J Med; 2005 Sep 01; 353(9):872-5. PubMed ID: 16135831
    [No Abstract] [Full Text] [Related]

  • 19. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
    O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA.
    J Bone Miner Res; 1992 Jan 01; 7(1):81-7. PubMed ID: 1549961
    [Abstract] [Full Text] [Related]

  • 20. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM, Scott LJ.
    Drugs; 2007 Jan 01; 67(5):793-804. PubMed ID: 17385948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.